Healthcare & Life Sciences
T3 Pharmaceuticals
Germany
series-c-plus
series-c-plus
Stage
1
Investors
About
T3 Pharmaceuticals develops novel therapies focused on precision medicine approaches for the treatment of thyroid-related diseases and cancers.
Explore T3 Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.